AbbVie: ‘We Looked At Biosimilars, We Are Not Interested’

Originator Prefers Using Manufacturing Capacity For Branded Drugs

 
• By Dean Rudge
  
Money questions (Ditty_about_summer/Shutterstock.com)
AbbVie had considered biosimilars • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products